Viromed Medical AG Expands Management Board

Viromed Medical AG has announced the expansion of its Management Board with the appointment of Christian Strauch, effective from January 1, 2025. Christian Strauch brings a wealth of experience in the healthcare sector, having held prominent roles in multiple companies. He joins Viromed as they face significant challenges in expanding their cold plasma technology globally.

Uwe Perbandt, who will now serve as Chairman, expressed enthusiasm for working alongside Strauch. The addition aims to leverage Strauch's expertise and international contacts to bolster Viromed's growth strategy. Jan Delphendahl, Chairman of the Supervisory Board, highlighted Strauch's international experience as pivotal for addressing upcoming challenges.

Viromed Medical AG, listed since October 2022, focuses on the development and distribution of medical products, particularly in innovative plasma technology. With this leadership enhancement, Viromed aims to capitalize on growth opportunities within the medical field.